The above pan-cancer analysis further showed the importance of IFIT1 in TME, and since immunosuppressive TME is a major obstacle to immunotherapy, we next investigated the effect of IFIT1 + TANs on immunotherapy response in in vivo models. Here, IFIT1 is linked to cancer.